home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
Post navigation
Previous Post
Previous
Kronos Bio Reports Positive Results of Preclinical Study of KB-0742, an Investigational CDK9 Inhibitor, Demonstrating Potency, Selectivity and Anti-tumor Activity in Prostate Cancer Model
Next Post
Next
Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer